Form 4: National Healthcare Corp Director Burgess Receives Stock Option Grant

Sentiment:

SEC Form 4 Filing


Director Ernest G. Burgess III reports the acquisition of 7,500 stock options in National Healthcare Corp, granted on May 9, 2024, under the 2020 Omnibus Equity Incentive Plan.

Summary

  • Ernest G. Burgess III, a director at National Healthcare Corp (NHC), reported a transaction involving derivative securities.
  • On May 9, 2024, Burgess acquired 7,500 stock options with an exercise price of $96.03.
  • These options, granted under the 2020 Omnibus Equity Incentive Plan, become exercisable on May 9, 2025, and expire on May 8, 2029.
  • Burgess also directly owns options from previous grants: 5,500 from 2020, 7,500 from 2021, 7,500 from 2022, and 7,500 from 2023.
  • Additionally, Burgess indirectly owns 86,150 shares of common stock held in the BTCP Trust, where he serves as trustee.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard corporate practice of incentivizing directors with stock options, which is generally viewed favorably as it aligns management's interests with shareholders.

Positives

  • The grant of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards increasing the company's stock value.
  • The vesting schedule (exercisable from May 9, 2025) encourages long-term commitment from the director.

Industry Context

Stock option grants are a common practice in the healthcare industry to incentivize executives and align their interests with shareholders. The specific terms of the grant, such as the exercise price and vesting schedule, are typical for executive compensation packages.

Comparison to Industry Standards

  • Comparing the option grants to similar healthcare companies, the exercise price is at a premium to the current share price, which is common to incentivize future growth.
  • The vesting schedule of one year is fairly standard, aligning with typical industry practices for executive compensation.
  • Companies like Brookdale Senior Living and HCA Healthcare also utilize stock options as part of their executive compensation packages, with similar vesting periods and performance-based criteria.

Stakeholder Impact

  • Shareholders may view the option grant positively as it incentivizes the director to increase shareholder value.
  • Employees may see it as a sign of confidence in the company's future.

Key Dates

DateDescription
05/07/2021Date exercisable for 2020 option grant
05/06/2022Date exercisable for 2021 option grant
05/05/2023Date exercisable for 2022 option grant
05/04/2024Date exercisable for 2023 option grant
05/09/2024Date of stock option grant and transaction date
05/09/2025Date exercisable for 2024 option grant
05/06/2025Expiration date for 2020 option grant
05/05/2026Expiration date for 2021 option grant
05/04/2027Expiration date for 2022 option grant
05/03/2028Expiration date for 2023 option grant
05/08/2029Expiration date for 2024 option grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.